Wright Don - Jun 11, 2024 Form 4 Insider Report for International Stem Cell CORP (ISCO.OB)

Role
Director
Signature
/s/ Russell Kern, as Attorney-in-Fact
Stock symbol
ISCO.OB
Transactions as of
Jun 11, 2024
Transactions value $
$0
Form type
4
Date filed
6/13/2024, 04:05 PM
Previous filing
Jun 16, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISCO.OB Stock Option (Right to Buy) Award $0 +30K $0.00 30K Jun 11, 2024 Common Stock 30K $0.12 Direct F1
transaction ISCO.OB Stock Option (Right to Buy) Award $0 +361K $0.00 361K Jun 11, 2024 Common Stock 361K $0.12 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options shall vest on the earlier of (i) June 11, 2025 or (ii) the date of the 2025 Annual Meeting of Stockholders.
F2 Options shall vest in four equal quarterly increments, beginning September 11, 2024.